HF
IMRX icon

HRT Financial’s Immuneering IMRX Stock Holding History

HRT Financial’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$223K Buy
+42,456
New +$218K ﹤0.01% 3124
2024
Q3 		– Sell
-21,364
Closed -$27K – 2758
2024
Q2 		$27K Buy
+21,364
New +$35.1K ﹤0.01% 1905

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HRT Financial's IMRX Position: Q1 2026 in Review

HRT Financial opened a new position in Immuneering (IMRX) in Q1 2026: 42,456 shares worth $223K. The stake represents ﹤0.01% of the portfolio and ranks #3124 among its holdings. This is a return to the name: HRT Financial previously reported a position in IMRX as recently as Q2 2024.

HRT Financial first reported a position in IMRX in Q2 2024 and has held it in 2 quarters since. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.

  • HRT Financial held 42,456 shares of Immuneering worth $223K as of Q1 2026.
  • Immuneering was a new HRT Financial position in Q1 2026.
  • Immuneering made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3124 holding.
  • HRT Financial first reported a position in Immuneering in Q2 2024 and has held it in 2 quarters since.
  • 95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.